| ASPsiRNA ID | Pairing of target region (top) and ASP-siRNA (bottom) | Efficacy (mut)(%) | Efficacy (wt) (%) | Diff | Gene | Disease | Mutation | RefSNP | Analysis | Pubmed ID |
|---|---|---|---|---|---|---|---|---|---|---|
| ASPsiRNA ID | Mutant allele/ASP-siRNA | Efficacy for mutant(%) |
Efficacy for wild (%) |
Relative Difference (%) | Gene | Disease | Mutation | RefSNP | Analysis | Pubmed ID |
| aspsirna1833 | CUUAUUGGAGAGAGCACGA GAAUAACCUCUCUCGUGCU |
93 | NA | NA | CD46 | Hemolytic uremic syndrome | c.104G>A, p.Cys35Tyr | rs12190959 | 
|
|
| aspsirna1841 | CUUAUUGGAGAGAGCACGA GAAUAACCUCUCUCGUGCU |
93 | NA | NA | CD46 | Hemolytic uremic syndrome | c.104G>A, p.Cys35Tyr | rs12190959 |
|
|
| aspsirna3902 | GGAGUGUAACGAUUACAUC CCUCACAUUGCUAAUGUAG |
97 | NA | NA | TGFBR2 | NA | NA | NA |
|
|
| aspsirna3910 | GCUUUGUCGUGUGGAGCAU CGAAACAGCACACCUCGUA |
88 | NA | NA | LTB4R | NA | NA | NA |
|
|
| aspsirna3926 | GUAACUGAAGGCUCGCUCA CAUUGACUUCCGAGCGAGU |
95 | NA | NA | CTGF | NA | NA | NA |
|
|
| aspsirna3942 | GGCUCAAGUGAUUCUCCUG CCGAGUUCACUAAGAGGAC |
96 | NA | NA | PNPT1 | NA | NA | NA |
|
|
| aspsirna3950 | GGCUCAAGUGAUUCUCCUG CCGAGUUCACUAAGAGGAC |
96 | NA | NA | PNPT1 | NA | NA | NA |
|
|
| aspsirna3994 | GCAAAUUCACCACGGCAAG CGUUUAAGUGGUGCCGUUC |
90 | NA | NA | DDR2 | NA | NA | NA |
|
|
| aspsirna3998 | GCAAAUUCACCACGGCAAG CGUUUAAGUGGUGCCGUUC |
90 | NA | NA | DDR2 | NA | NA | NA |
|
|
| aspsirna4018 | GAGACUCCGUAGACGAAGA CUCUGAGGCAUCUGCUUCU |
90 | NA | NA | PDGFRB | NA | NA | NA |
|
|
| aspsirna4042 | GGAAUCGCAGGCAUCAUGG CCUUAGCGUCCGUAGUACC |
81 | NA | NA | SLC12A5 | NA | NA | NA |
|
|
| aspsirna4094 | GUAUUUGUCACCAAGCUCA CAUAAACAGUGGUUCGAGU |
91 | NA | NA | CCL2 | NA | NA | NA |
|